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Exposure of guinea pigs to UV A (320-400 run) radia-
tion following administration of 8-methoxypsoralen by 
gavage (re'ferred to by the acronym, PUV A) or exposure 
to UVB (290-320 nm) radiation, produced suppression of 
the cutaneous delayed hypersensitivity reaction at the 
site of exposure to radiation and at distant nonexposed 
sites, In these experiments, the animals were immunized 
by injection of dinitrophenyl-bovine gamma-globulin 
(DNP-BGG) in complete Freund's adjuvant and delayed 
hypersensitivity responses were provoked by intrader-
mal injections ofDNP-BGG, DNP and BGG on the flanks. 
Exposure to erythemogenic doses of either PUV A or 
UVB radiation for 7 days prior to immunization and for 
the 7 days between immunization and challenge (total 
period of radiation: 14 days) produced inhibition of re-
sppnses to each of the test substances. In addition, treat-
ment with erythernogenic doses of PUV A either for 7 
days prior to immunization or during the interval be-
tween immunization and challenge with DNP-BGG, in-
hibited the delayed hypersensitivity responses at the site 
of irradiation and at a nonexposed site. These findings 
suggest that in vivo exposure to nonionizing radiation 
leads to. both local and systemic a lteration of certain 
immune responses. 
Exposure to ul traviolet (UV) radiation alters cu taneous cell-
med iated immune responses. In the guinea pig allergic contact 
dermatitis to 2,4 dinitrochlorobenzene (DNCB) was depressed 
by multiple exposures of the challenge s ite to UVB (290-320 
nm, "sunburn") ra diation [1,2] or to UV A (320-400 nm) radia-
tion fo llowing administration of 8- m ethoxypsoralen [3]. In mice, 
cell -dependent delayed-type hypersensitivi ty responses to hap-
tens were depressed by chron ic exposure to UVB radiation 
[4,5]. The depression observed in t h ose studies was not confined 
to exposed sites. In t h e present study we examined in t h e guinea 
p ig t h e effect of PUV A a nd UVB radiation on t h e development 
of delayed hy p ersensitivity (DH) following immunization w it h 
a hapten-protein conjugate emulsified in complete Freund's 
adj uvant (CFA). O ur experime n ts indicate that bot h types of 
radiation cause a s ignificant depression of DH responses both 
locally at t h e s ite of exposure and at a distant no n exposed s ite. 
MATERIALS AND METHODS 
Female, Hartley strain , a lbino guinea pigs weighing 500-600 gm were 
used in these experiments. 6 x 7 cm sites on the cephalad portion of 
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the dorsal thorax were exposed to rad iation. The same location was 
used for comparison in control anima ls. These sites were clipped a nd 
dep ilated (Neet: thioglyco lic ac id) on alternate days throughout the 
experiments. An addit ional site, referred to as "non irradiated area" in 
animals that were exposed to rad iation, was located on the midportion 
of the back and was clipped and depilated on the day prior to injection 
of the cha llenge doses of test substances. This area was protected from 
exposure to rad iation by the presence of hair and the gloved hand of 
the technician. 
Im.m.unization 
I Jlg dinitrophenyl-bovine gamma-globulin (DNP-BGG), (50 moles 
ONP I mole globulin; Calbiochem, San Diego, CAl emulsified in 1 ml 
CF A was admin istered by footpad injection. 
Elicitation of Hypersensitivity 
T hree test substances were used: 0.01 Jlg DNP-BGG; 0.01 Jlg dinitro-
phenol (DNP) (Sigma, St. Louis, MO) ; and 0.01 /lg bovine gamma-
globulin (BGG) (Calbiochem) . These substances were administered in 
0. 1 ml normal saline by in t radermal injection into the back. The 
cha llenge dose of these solu tions was administered 7 or 14 days a fter 
immuniza tion. The responses to the challenge dose were evaluated by 
2 observers 24 hr afte r administration on a scale of: 0 = no reaction, 1+ 
= erythema, and 2+ = erythema and induration. In preliminary exper-
iments it was established that the immunization a nd challenge doses of 
ONP-BGG were the lowest t hat produced a positive test response in 
all a nima ls tested . Injec tion of cha llenge doses of the test substances 
i'n to a nimals that had not been immunized with DNP-BGG produced 
no reaction at the s ite of administration. In addit ion, it was established 
that t he administration of the 3 test solu tions to 2 areas of the back of 
5 control anima ls gave identical responses to those seen in 5 control 
anima ls that were injected with the test solutions in only one area. 
Exposure to PUVA 
8-Methoxypsoralen (12 mg/kg body weight) was administered daily 
by gavage and 1 hI' later the animals were exposed to UV A radiation in 
a U-shaped bench radiator lined with 26 PUVA flu orescent bu lbs 
(Sylva nia, Danvers, MA) . T he average irradiance fo r the in tegrated 
320-400 nm waveband at the level of the animals' backs was 45 w/ m' 
as measured by a cosine-corrected UV spectroradiometer sy ·tem (lL 
783, International Light, Inc., Newburyport, MA) . The erythemal re-
sponse to radiation was evaluated 24 hr after the last expOSU1'e using a 
scale of: 0 = no reaction, 1.+ = pink erythema, 2+ = red erythema; 3+ 
= red erythema with swelling, and 4+ = in tense erythema wi th swell ing 
and scaling. In preliminary studies it was established that t he response 
to an injected antigen could be evaluated in the presence of a 3+ 
erythema. Four animals that had been immunized with DNP-BGG 6 
days previously were exposed to 16.2 x 1.0" J 1m 2 UV A rad iation one 
hour after administration of 8-methoxypsoralen and 24 hl' later a 
challenge dose of' DNP-BGG was injected in to the i.rradiated area. 
Evaluation 24 hI' later revealed a 3+ erythema due to the irradiation 
a nd a 2+ response due to the challenge dose of antigen . The erythemal 
response to ONP-BGG was a darker reddish-purple color in comparison 
to the pinkish-red response to radiation, and induration from antigenic 
cha llenge was seen to be superimposed on the edema resulting from 
the exposure to rad iation. During the s tudy it was found that the 
scaliness of the skin which accompanied a 4+ erythema response made 
it difficul t to evaluate the response to the injected test solu t ions; 
therefore, sites showing this degree of erythema were not evaluated. 
Exposu.re to UVB Radia.tion 
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Exposures were given da ily in a U-shaped bench radiator lined with 
26 FS-40 Sunlamps (Westinghouse, Bloomfield, NJ). The average ir-
June 1981 
r adiance for the in tegrated 280-320 nm waveband was 820 mw/ m". As 
with PUV A, the response to radiation was evaluated 24 hr after the 
last exposure using the 0 to 4+ scale. 
Design of the Study 
Study 1: An imals were immunized wi th DNP-BGG in CFA and the 
c hallenge dose of the test solutions was administered 7 days later. Five 
gro ups were examined: untreated animals; animals treated with 8-
methoxypsoralen but not exposed to UVA radiation (psoralen control) ; 
a nimals exposed to UV A radiation but not treated with 8-methoxyp-
s oralen (UVA control); PUVA-exposed (PUVA #1) and UVB-exposed. 
All treatments were commenced 7 days prior to immunization and 
continued for 14 days until the day of challenge. 
Study 2: Animals were im munized with DNP-BGG in CF A and a 
challenge dose of' ONP-BGG was administered 7 days later. Seven 
gro ups were examined: untreated animals, and PUV A #2-7 which were 
e xposed to varying doses of UV A radiation after administration of 8-
methoxypsora len. In PUV A #2, 4 and 6, the animals were treated daily 
fo r the 7 days prior to immunization. In PUVA #3, 5 and 7, the animals 
w ere treated da ily for the 7 days between immunization and adminis-
tration of the challenge dose of ONP-BGG. 
S tudy 3: Animals were immunized with DNP-BGG in CFA and a 
c ha llenge dose of ONP-BGG was administered 14 days later. Two 
groups were exa mined: un treated animals, and PUVA-exposed (PUVA 
#8) animals wh ich were treated daily for the 14 days between immu-
nization and challenge. 
Analysis of R esults: Resu lts were analyzed using the Smirnov test 
[6]. This is a nonparametric test that permits distinction between 
different experimental samples without making assumptions about the 
underlying distributions. 
Histology: The sites of injection of the eliciting dose of ONP-BGG 
w e re excised 24 hI' after the injection in three animals of Control #1 
and three animals of' PUVA # 1. These biopsy specimens were em-
b e dded in paraffin, sectioned and stained with hematoxylin and eosin, 
the slides were examined by light microscopy. 
RESULTS 
Study I 
This study examined the effect of radiation exposures com-
menced 7 days prior to immunization and cont inued daily for 
14 days until the day of challenge. Results are summarized in 
Table I. Most of the control animals gave strong positive 
responses of erythema and induration (2+) at sites of injection 
of DNP-BGG. Erythema without any induration was seen in 
many control animals at the site of injection of DNP. All 
animals given 8-methoxypsoralen without subsequent exposure 
to rad iation o r exposed to 8.1 X 104 J/m2 UVA radiation had 
2+ positive responses to DNP-BGG. 
Daily t reatm ent with PUV A or UVB radiation for 7 days 
prior to immunization and for the 7 days between immunization 
and chall enge (PUV A #1 and UVB group) resulted in a 3+ 
eryth emal response. Compared to the responses in the control 
animals, the re was a significant reduction (p < 0.01) in the DH 
responses to all test solutions in the areas exposed to radiation. 
The responses to DNP-BGG and BGG were also significantly 
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reduced (p < 0.01) in the nonirradiated areas of animals treated 
with PUV A or UVB radiation. The radiation-induced diminu-
tion of DH responses was not significantly different (p > 0.05) 
between the PUVA-treated a nd UVB-exposed animals. The 
reduction in th e responses to DNP in the nonirradiated area 
was significant (p < 0.01) in th e PUV A-treated animals but 
although a trend towards a similar reduction was seen in the 
UVB-exposed animals, it did not reach a significant level (p > 
0.05). 
Study 2 
This study examined th e effect of 7 daily treatments with 
PUV A administered eith er prior to immunization or between 
the time of immunization and challenge with DNP-BGG. The 
results are summarized in Table II. Nine of the control animals 
showed a strong positive (2+) response to DNP-BGG at t he 
site of challenge. The response to DNP-BGG was reduced (p 
< 0.05) at the site of exposure to 2.7 X 104 J / m2 UVA radiation 
in animals treated with PUV A for 7 days prior to immunization 
(PUV A #2) and in animals treated for th e 7 days between 
immunization and challenge (PUV A #3). The responses in the 
noni.rradiated areas in both these groups also tended to be 
decreased. The higher radiant exposure doses in PUV A #4, 6 
a nd 7 resul ted in a significant (p < 0.01) reduction in the 
responses to DNP-BGG in the nonirradiated area. The trend 
for a reduced response in PUV A #5 was not significant (p > 
0.05) but this result may have been partly due to the small 
number of a nimals in that group. 
In all irradiated groups, t he responses to challenge doses of 
DNP-BGG were less (p < 0.05) in t he irradiated areas as 
compared to the responses in nonirradiated areas. There is 
evidence that the reduction of DH responses in PUV A-tJ'ea ted 
animals is related to the dose of radiation. The responses to 
cha ll enge doses of DNP-BGG at nonirradiated sites in PUVA 
#6 and 7 (8.1 X 10" J / m2) was significantly less (p < 0.01) than 
the responses at the corresponding sites in PUVA #2 and 3 (2.7 
X 104 J / m 2 ). Fmthermore, it appears that treatment with 
PUV A prior to immunization is more effective in suppressing 
DH response than treatment with PUVA prior to challenge. 
The DH responses in PUVA #2 and 4 (treated prior to immu-
nization) were significantly less (p < 0.01) t han t he responses 
in PUVA #3 and 5 (treated prior to challenge). 
Study 3 
This study examined the effect of 14 daily PUV A treatments 
given between the time of immunization a nd challenge with 
DNP-BGG. The resul ts are summarized in Table III. Treat-
ment with PUV A for 14 days after immunization resulted in a 
3+ erythemal response and a significant reduction (p < 0.01) of 
the response to DNP-BGG in both the irradiated and nonirra-
diated areas as compared to th e responses in control animals. 
PUV A #1 and 8 were exposed to the same dose of PUV A over 
TABLE 1. Results of study 1" 





PUVA 1 38 
UVB 20 
Treatment 
No exposure to 8- methoxypsoralen or 
radiation 
8-methoxypsoralen (12 mg/ kg) 
8. 1 x 10" J / m" UVA radiation daily 
8-methoxypsoralen (12 mg/ kg) and 2.7 
x 104 J /m~ UV A radiation daily 
4.9 X 10" Ji m" UVB radiation daily 



















R esponse a t site of cha llenge in 
rrrndia ted area Nonirradiated area 
o 1+ 2+ 0 1+ 2+ 
2 0 18 
0 1 19 
5 14 1 
0 0 5 
0 0 5 0 0 5 
35 3 0 17 14 7 
26 3 0 13 14 2 
29 0 0 21 7 
15 4 I 6 12 2 
8 2 0 3 6 1 
10 0 0 6 4 0 
a Guinea pigs were immunized with ONP-BGG in CFA by footpad inj ection and the challenge dose of DNP-BGG, BGG and DNP was 
administered 7 days later. Exposed animals were irradiated daily for 7 days prior to immunization and for 7 days between im munization and 
c ha llenge. 
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TABLE II. Results of study 2" 
UVA radiation dose J/m'/day Response at s ite of challenge in 
Group No. of Ani-
mals Prior to immunization Prior to elicitation 
Erythemal response 
to radiation 















2.7 x 10' 
2.7 X 10" 
5.4 x 10' 
5.4 X 10' 
8.1 x 10' 
8.1 X 10' 
a 1+ 
2+ 5 0 





2+ 0 1+ 2+ 
0 1 9 
0 0 4 1 
0 0 6 4 
5 0 0 
3 2 
10 0 0 
5 0 0 
"Guinea pigs were immunized with DNP-BGG in CFA by footpad injection and the cha llenge dose of DNP-BGG was administered 7 days 
later. Exposed animals were irradiated da ily for t he 7 days either prior to immunization or between immunization and cha llenge. 
/, Response could not be evaluated due to scaliness of skin . 
TABLE III. Results of study 3" 
Group No. of Anima ls Treatmenl 
E rythema l re-
sponse to radiUM 
t ion o 
Response al site of cha llenge in 
Irradiated a rea Non i'Tad iuted area 





No exposure to B-methoxypsora len 
or UV A rad iation 
B-methoxypsoralen (12 mg/kg) and 
2.7 x 10"' J/m2 UVA radiation 
daily 
3+ 5 o 
o o 5 
o o 5 o 
"G uinea pigs were immunized with DNP-BGG in CFA by footpad injection and the cha llenge dose of DNP-BGG was admin istered 14 days 
later. Exposed animals were irradiated daily for the 14 days between immunization and cha llenge. 
14 days. When 7 of t he PUV A treatments were given prior to 
immunization (PUV A #1) the suppression of DH in nonirra-
diated areas was greater (p < 0.01) than if all PUVA treatments 
were given between immunization and challenge with DNP-
BGG (PUVA #8) . 
Histologic examination of the sites of challenge with antigen 
conflrmed the gross observations of induration and erythema. 
In the control, nonirradiated animals the site of a 2+ response 
showed dermal edema and a marked infiltrate of macro phages, 
lymphocytes and eosinophils (Fig 1). In contrast, this dermal 
inftltrate was absent in PUV A-exposed animals at both i.rrad i-
ated and nonirradiated (Fig 2) sites that were scored as showing 
o responses. 
DISCUSSION 
Exposure of guinea pigs to either PUV A or UVB radiation 
produced local and systemic suppression of DH responses to an 
injected antigen. Daily treatment with either radiation com-
mencing 7 days prior to immunizaLon and continuing for the 7 
days between immunization and challenge resulted in ery thema 
and swelling of the exposed area and a reduction of the DH 
responses following' challenge in both the exposed area and an 
adjacent. nonirradiated area (Table I). When challenge with 
ant igen was delayed until 14 days after immunization, and 
PUV A treatment was gi'ven daily during that period, the DH 
responses were also reduced (Table III) . In addition , animals 
t hat were treated with PUV A for only the 7 days prior to 
immunization or the 7 days between immunization and elicita-
t ion of DH showed reduced responses in comparison to un-
treated animals (Table II). Exposure to radiation prior to im-
munization produced greater suppression of DH than did ex-
posure to the same dose of radiation after immunization. Nor-
mal DH responses were seen, in cont rol animals t hat had 
received no treatment, or which were t reated with psora len 
alone or UV A radiation alone. 
All doses of UV rad iation used in this study resulted in a 
similar degree of suppression of DH within the sites exposed to 
radiation. However, wi thin the nonirradiated sites of animals 
treated with 8-methoxypsoralen, higher doses of UV A radiation 
administered at a distant site produced a greater red uction of 
DH. However, both PUV A and UYB radiation caused more 
suppression of DH in areas exposed to radiation than in nonir-
radiated areas. 
FIG I. S ite of cha llenge with DNP-BGG in a control, un treated 
guinea pig; graded as a positive (2+) response. Note t he inflammatory 
infi lt rate which was composed of lymphocytes, macrophages and eosin-
ophi ls (reduced from, x200), 
Several explanations may be considered for the effect of UV 
radiation on DH responses, The suppression of DH produced 
by exposure to radiation might be due to a du"ect effect on cells, 
such as lymphocytes or macrophages, Both UV A and UVB 
radiation penetrate to the level of the cutaneous blood vessels 
[7] ; thus, cells wi thin the skin and in the blood a nd lym phatic 
vessels of the skin might be affected. Lymphocytes have been 
found to be sensitive to radiation; for example, in vitro exposure 
to 1 J/ml of UVB radiation can impair trypan blue dye exclu-
sion by these cells (8). It seems unlikely that the effects observed 
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FIG 2. Site of challenge with DNP·BGG in a nonirradiated area of 
a PUVA·treated guinea pig; graded as a negative (0) responSt. Note 
t h e absence of an inOammatory response (reduced from, Xl OO). 
in the presen t experiments are entirely .attributa ble to a toxic 
effect of radiation on cells of the lymphocyte and monocyte 
line, because the field of exposure to radiation was less tha n 
10% of the surface area of the animals, and as few as 7 exposllJ'es 
resul ted in a complete inhibi tion of the DH response. However , 
exposure times of up to 30 min did permit repeated circulation 
of blood through th e site of radiation. Furthermore, repeated 
expOSUl'e to UV radiation caused maTked dilatation of blood 
vessels and accumulation of inflammatory cells and edema 
fluid . These events would be expected to incI'ease the propor-
tion of circulating cells actually exposed to UV radiation. 
An a lternative possibility is that exposure to radiation affects 
components of the immune system indirectly via the release of 
m ediators from t he exposed skin. This mechanism might ex-
plain the local and systemic suppression of DH by br~ef ex,?o-
s W 'es of small areas of skin. Prostaglandins (9J and histamIne 
[10J are released from s kin as a result of exposure to UVB 
radiation in humans and both ar e importan t in th e control of 
immune responses (11,12]. The mediators of PUV A-induced 
erythemal responses in humans are unknown and there is li tt.le 
information on possible m ediators of UV -induced erythema In 
gu inea pigs. 
Different effects of radiation m ay be involved in t he suppres-
s ion of DH responses depending on the relationship between 
the time of exposure and the time of immunizat ion or challenge . 
The effect of radia tion on components of the immune system 
prior to immunization would probably not be selective. F?r 
example, the number of viable lymphocytes or monocytes In 
the a nimals may be redu ced by the exposure to radiation so 
that fewer cells are available to mount an immune response. 
Alterna tively, the function of macrophages may be impa ired 
rather than their number only being reduced. A defect of 
antigen-presenting cell fun ction in UV-irradia.te? animals has 
b een reported [5]. Mice exposed to UVB radiatIOn h ad a de-
c reased delayed type hypersensitivity response to haptens and 
by cell transfer experiments t his was shown to be due to failure 
of ant igen presentation during the induction phase of the Im-
mune response. TNP-derivatized cells from the spleen of UV-
treated donor mice could not induce hapten-specific DH re-
sponses in UV-treated syngeneic mice. This defect was associ-
UV RADIATION AND DELAYED HYPERSENSITIVITY 487 
ated with the development of antigen-specific suppressor T 
cells . T his mechanism may be at least partly responsible for 
the radiation-induced reduction of DH responses observed in 
the present study. 
Exposure to u ltraviolet radiation after immunization may 
have a more selective effect on the DH response. ActIvated 
lymphocytes have been found to be more sensitive to UV 
I:adia t ion as co mpal'ed to resting cells (1 3]. Radiation may 
selectively reduce the number or alter the function of lympho-
cytes sensit ized to the antigen and this may resu lt in a failure 
to recrui t additional cells both fo r the induction and elicitation 
phase of t he in1mune response. Fmthermore, radiation may 
alter the cha racter of the im mune response to the Injected 
a ntigen by favoring the development of antigen-specific sup-
pressor lymphocytes. Fina lly, it is possible that exposure to 
radiation alters the local infla mma tory response at the sIte of 
e licitation of delayed hypersensitivity. For example, mediators 
released from the skin as a result of exposure to radiation may 
alter vasculal' responses both locally at the site of exposm e and 
at distant nonexposed sites. 
The model used for the present study has previously been 
emp loyed by other investigators to dissociate humoral and DH 
responses to immunization [14,15]. T hese studies showed that 
fo llowing injection of a hapten-protein conjugate in CFA, a DH 
response can be elicited and appears to be directed mainly 
towards the carrier protein; the humoral response develops 
later and is d irected primarily towards th e ha pten. The present 
report co ncerns only the DH responses to DNP-BGG . Although 
the an ticipated strong responses to cha llenge with DNP-BGG 
and BGG were seen in control animals at 7 days after immu-
nization wi th DNP-BGG in CFA, a smprising finding was that 
D NP a lone a lso produced a response, albeit usually only in th e 
form of erythema. This response was also suppressed by expo-
sure to rad iation but the mech anism of the response a nd the 
sign ificance of its suppression are uncertain. A DH response 
directed towards the hapten ar sanilic acid has been reported 
(15J, but a DH response does not appear to have been reported 
for the ha pten used in the present study. 
Possibly, exposure to PUV A a nd UVB radiation ha similar 
effects on both allergic contact dermatitis and delayed hyper-
sensitivity . Exposure of the challenge si t~ to PUVA or UyB 
radiation has been shown to inhibi t allergIc contact dermatitIs 
to DNCB in the guinea pig (2,3]. In further studies (u npublished 
observations) it has been found that exposm e of th e whole back 
of the animal to radiation results in both local and systemic 
suppression of contact allergy and it is not neceSSaTY to include 
the site of challenge. 
This study provides further evidence t hat exposure to non-
ionizing radia t ion can influence immune responses in vivo. The 
beneficial effects of UVB phototherapy and PUV A photoche-
motherapy in certa in skin diseases may be mediated via an 
alteration of the immune responses which aTe thought to be 
invo lved in the pathogeneses of several of these diseases. S i.m-
ilal'ly, some of th e adverse effects of exposUJ'e to nOnIonIzIng 
radiation, for example skin cancer, may also resul t from alter-
ations of immune function, rather than being caused directly 
by radiation. 
The authors axe grateful to Ms. Dale Kristoff, Ms. Jane Meloni, Mr. 
Nicholas DeCola, and Mr. Howard Lawson, whose enthusiasm and 
attention to detail made this s tudy possible. 
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Announcement 
The biannual Dermato Logy and Allergy Section of the American Society for Clinical Pharmacology and 
Therapeutics will be at Disney World, Lake Buena Vista, Florida on March 17-20, 1982. M eeting and 
membership information is obtained Ii·om Mrs. E . Galasso, ASCPT, 1718 Gallagher Rd ., Norristown, PA 
1940l. Abstracts should be mailed by Sept 11981, to Howard Maibach , M.D., University of California, 
Medical Center , 400 Parnasslls Ave., Room A-342, San Francisco, CA 94143. 
